1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 1: Demographics and clinical information of patients of the paraclinoid cohort compared with data of unruptured aneurysms in other locations treated with endovascular therapy
Unruptured Paraclinoid Unruptured Other Locations P Sex Female 109 (92%) 70% <.001* Male 9 (8%) 30% Female:Male 12.6:1 2.4:1 Mean age (yr) 55.19 ± 11.7 (30–79) 57.5 ± 12.8 .030* Risk factors Hypertension 53 (45%) 55% .076 Diabetes mellitus 5 (4%) 9% .080 Tobacco abuse Current 35 (30%) 39% .115 Prior 34 (29%) 30% Personal history of cerebrovascular disease 16 (14%) 19% .222 Family history of intracranial aneurysm 34 (29%) 15% .001* Multiple aneurysms 47 (40%) 33% .271 Length of hospital stay (days; mean ± SD) 1.54 ± 2.6 1.9 ± 2.9 .080
-
↵* Statistically significant.